The strong E-cadherin expression in IBC, being a highly invasive, poorly differentiated tumour with prominent lymphovascular invasion and high incidence of lymph node and distant metastasis, therefore constitutes a striking difference between IBC and non-IBC. This evidence concerns the gene CDH1 and inflammatory breast carcinoma.